{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:48Z","timestamp":1792097388259,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Outstanding Young Doctor Training Program of Jiangsu Province Hospital of Chinese Medicine","award":["2024QB001"],"award-info":[{"award-number":["2024QB001"]}],"id":[{"id":"https:\/\/ror.org\/04py1g812","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Programs of Jiangsu Province Hospital of Chinese Medicine","award":["Y25102"],"award-info":[{"award-number":["Y25102"]}],"id":[{"id":"https:\/\/ror.org\/04py1g812","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03398-0","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:31:03Z","timestamp":1788845463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pachymic acid exhibits synergistic antitumor efficacy with lenvatinib in hepatocellular carcinoma by targeting PPAR\u03b3 to inhibit glycolysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Zhiwei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"3398_CR1","doi-asserted-by":"publisher","first-page":"e18761429310703","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, Angelico R, Toti L, Conte L, Coppola A, Tisone G, Manzia TM. Mechanism, Potential, and Concerns of Immunotherapy for Hepatocellular Carcinoma and Liver Transplantation. Curr Mol Pharmacol. 2024;17:e18761429310703. https:\/\/doi.org\/10.2174\/0118761429310703240823045808.","journal-title":"Curr Mol Pharmacol"},{"key":"3398_CR2","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.2174\/0115701808334721241111073635","volume":"21","author":"N Zulfa","year":"2024","unstructured":"Zulfa N, Fariha S, Pranay W, Chirag G, Mohd I, Amin G. A Systemic Review on Phytochemicals and Novel Approaches for the Management of Hepatic Cancer. Lett Drug Des Discov. 2024;21:4221\u201346. https:\/\/doi.org\/10.2174\/0115701808334721241111073635.","journal-title":"Lett Drug Des Discov"},{"key":"3398_CR3","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12325-024-03068-5","volume":"42","author":"K Ndirangu","year":"2025","unstructured":"Ndirangu K, Paine A, Pilkington H, Trueman D. An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma. Adv Ther. 2025;42:977\u201394. https:\/\/doi.org\/10.1007\/s12325-024-03068-5.","journal-title":"Adv Ther"},{"key":"3398_CR4","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.31557\/APJCP.2025.26.6.1943","volume":"26","author":"N Remitha","year":"2025","unstructured":"Remitha N, Dewi N, Yogananda IKC, Sasmana I, Kusuma I, Supadmanaba IGP, Sindhughosa DA, Mariadi IK. Efficacy of Lenvatinib Versus Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2025;26:1943\u201352. https:\/\/doi.org\/10.31557\/APJCP.2025.26.6.1943.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3398_CR5","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.62347\/PBLA2928","volume":"17","author":"Y Hou","year":"2025","unstructured":"Hou Y, Gao Z, Han Y, Liu C, Su X, Zhang D. Comparison of survival benefit and safety profile between lenvatinib and donafenib as conversion therapy in patients with hepatocellular carcinoma. Am J Transl Res. 2025;17:3496\u2013504. https:\/\/doi.org\/10.62347\/PBLA2928.","journal-title":"Am J Transl Res"},{"key":"3398_CR6","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2174\/1570180820666230601113529","volume":"21","author":"Y Yuguang","year":"2024","unstructured":"Yuguang Y, Hui T, Cong M, Xin Z, Jiawen K, Yunqiang T. Analysis of the Safety and Effectiveness of Lenvatinib\u2009+\u2009TACE-HAIC\u2009+\u2009PD-1 Inhibitor for Intermediate and Advanced Hepatocellular Carcinoma. Lett Drug Des Discov. 2024;21:2035\u201345. https:\/\/doi.org\/10.2174\/1570180820666230601113529.","journal-title":"Lett Drug Des Discov"},{"key":"3398_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/hepr.14173","volume":"55","author":"Y Takehara","year":"2025","unstructured":"Takehara Y, Waki Y, Morine Y, Saito Y, Teraoku H, Wada Y, Yamada S, Ikemoto T, Shimada M. Vascular endothelial growth factor released from lenvatinib-resistant hepatocellular carcinoma promotes malignant behavior and drug resistance through tumor-associated macrophages. Hepatol Res. 2025;55:752\u201362. https:\/\/doi.org\/10.1111\/hepr.14173.","journal-title":"Hepatol Res"},{"key":"3398_CR8","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.62347\/UJVP4361","volume":"14","author":"G Ye","year":"2024","unstructured":"Ye G, Ye M, Jin X. Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma. Am J Cancer Res. 2024;14:4113\u201371. https:\/\/doi.org\/10.62347\/UJVP4361.","journal-title":"Am J Cancer Res"},{"key":"3398_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s10020-025-01263-w","volume":"31","author":"K Yang","year":"2025","unstructured":"Yang K, Zhang X, Yang K, Liu S, Zhang J, Fu Y, Liu T, Wu K, Li J, Liu C, Huang Q, Qu K. Overexpression of c-Myc triggers p62 aggregation-mediated mitochondrial mitophagy in cabozantinib resistance of hepatocellular carcinoma. Mol Med. 2025;31:209. https:\/\/doi.org\/10.1186\/s10020-025-01263-w.","journal-title":"Mol Med"},{"key":"3398_CR10","doi-asserted-by":"publisher","first-page":"e18761429358008","DOI":"10.2174\/0118761429358008250305070518","volume":"17","author":"W Xu","year":"2024","unstructured":"Xu W, Liao S, Hu Y, Huang Y, Zhou J. Upregulation of miR-3130-5p Enhances Hepatocellular Carcinoma Growth by Suppressing Ferredoxin 1: miR-3130-5p Enhances HCC Growth via Inhibiting FDX1. Curr Mol Pharmacol. 2024;17:e18761429358008. https:\/\/doi.org\/10.2174\/0118761429358008250305070518.","journal-title":"Curr Mol Pharmacol"},{"key":"3398_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1570180820666230308115303","volume":"21","author":"Z Li","year":"2024","unstructured":"Li Z, Lizhi S, Shuchun G, Weihua Y, Yuanmei Z, Mingjie X. Buddleoside Inhibits Progression of Liver Cancer by Regulating NF\u03baB Signaling Pathway. Lett Drug Des Discov. 2024;21:166\u201373. https:\/\/doi.org\/10.2174\/1570180820666230308115303.","journal-title":"Lett Drug Des Discov"},{"key":"3398_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41420-022-01014-4","volume":"8","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yu Y, Wu P, Ye Q, Guo Y, Zhang X, Xi L, Li Q, Jin Y, Zhou D, Luo Y, Peng S, Li J. Lactate promotes the growth of patient-derived organoids from hepatopancreatobiliary cancers via ENO1\/HIF1\u03b1 pathway and does not affect their drug sensitivities. Cell Death Discov. 2022;8:214. https:\/\/doi.org\/10.1038\/s41420-022-01014-4.","journal-title":"Cell Death Discov"},{"key":"3398_CR13","doi-asserted-by":"publisher","first-page":"e2309204","DOI":"10.1002\/advs.202309204","volume":"11","author":"LP Zhao","year":"2024","unstructured":"Zhao LP, Zheng RR, Rao XN, Huang CY, Zhou HY, Yu XY, Jiang XY, Li SY. Chemotherapy-Enabled Colorectal Cancer Immunotherapy of Self-Delivery Nano-PROTACs by Inhibiting Tumor Glycolysis and Avoiding Adaptive Immune Resistance. Adv Sci. 2024;11:e2309204. https:\/\/doi.org\/10.1002\/advs.202309204.","journal-title":"Adv Sci"},{"key":"3398_CR14","doi-asserted-by":"publisher","first-page":"107139","DOI":"10.1016\/j.jbc.2024.107139","volume":"300","author":"J Yu","year":"2024","unstructured":"Yu J, Li S, Cheng S, Ahmad M, Chen C, Wan X, Wei S, Pan W, Luo H. Tanshinone analog inhibits castration-resistant prostate cancer cell growth by inhibiting glycolysis in an AR-dependent manner. J Biol Chem. 2024;300:107139. https:\/\/doi.org\/10.1016\/j.jbc.2024.107139.","journal-title":"J Biol Chem"},{"key":"3398_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11010-024-04989-z","volume":"480","author":"H Xiao","year":"2025","unstructured":"Xiao H, Liu L, Huang S. STK32C modulates doxorubicin resistance in triple-negative breast cancer cells via glycolysis regulation. Mol Cell Biochem. 2025;480:459\u201371. https:\/\/doi.org\/10.1007\/s11010-024-04989-z.","journal-title":"Mol Cell Biochem"},{"key":"3398_CR16","doi-asserted-by":"publisher","first-page":"100976","DOI":"10.1016\/j.drup.2023.100976","volume":"69","author":"S Wang","year":"2023","unstructured":"Wang S, Zhou L, Ji N, Sun C, Sun L, Sun J, Du Y, Zhang N, Li Y, Liu W, Lu W. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression. Drug Resist Updat. 2023;69:100976. https:\/\/doi.org\/10.1016\/j.drup.2023.100976.","journal-title":"Drug Resist Updat"},{"key":"3398_CR17","doi-asserted-by":"publisher","first-page":"e18761429260902","DOI":"10.2174\/0118761429260902230925044009","volume":"17","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Gu J, Yu H, Chen F, Long C, Maihemuti M, Chen T, Zhang W. Screening and Identification of ESR1 as a Target of Icaritin in Hepatocellular Carcinoma: Evidence from Bibliometrics and Bioinformatic Analysis. Curr Mol Pharmacol. 2024;17:e18761429260902. https:\/\/doi.org\/10.2174\/0118761429260902230925044009.","journal-title":"Curr Mol Pharmacol"},{"key":"3398_CR18","doi-asserted-by":"publisher","first-page":"156824","DOI":"10.1016\/j.phymed.2025.156824","volume":"143","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang H, Liang B, Qin L, Zhang M, Lv X, Hu S, Fan X, Xie W, Yang H, Huang G, Jing W. Zhao. Ponicidin promotes ferroptosis to enhance treatment sensitivity in Lenvatinib-resistant hepatocellular carcinoma cells through regulation of KEAP1\/NRF2. Phytomedicine. 2025;143:156824. https:\/\/doi.org\/10.1016\/j.phymed.2025.156824.","journal-title":"Phytomedicine"},{"key":"3398_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","volume":"24","author":"S Li","year":"2025","unstructured":"Li S, Chen X, Shi H, Yi M, Xiong B, Li T. Tailoring traditional Chinese medicine in cancer therapy. Mol Cancer. 2025;24:27. https:\/\/doi.org\/10.1186\/s12943-024-02213-6.","journal-title":"Mol Cancer"},{"key":"3398_CR20","doi-asserted-by":"publisher","first-page":"107016","DOI":"10.1016\/j.fitote.2025.107016","volume":"188","author":"JJ Tibenda","year":"2025","unstructured":"Tibenda JJ, Gu Q, Duan S, Song C, Du Y, Huang X, Zhao J, Nan Y, Yuan L. The mechanistic role of Poria cocos in cancer treatment: Antitumor activity and adjuvant potential in chemotherapy. Fitoterapia. 2025;188:107016. https:\/\/doi.org\/10.1016\/j.fitote.2025.107016.","journal-title":"Fitoterapia"},{"key":"3398_CR21","doi-asserted-by":"publisher","first-page":"106873","DOI":"10.1016\/j.biocel.2025.106873","volume":"190","author":"R Wang","year":"2026","unstructured":"Wang R, Tang D, Wu L, Ou L, Ding L, Jiang J, Wu Y. Bielong Ruangan decoction inhibits tumor growth and improves immune response in a hepatocellular carcinoma mouse model through gut microbiota. Int J Biochem Cell Biol. 2026;190:106873. https:\/\/doi.org\/10.1016\/j.biocel.2025.106873.","journal-title":"Int J Biochem Cell Biol"},{"key":"3398_CR22","doi-asserted-by":"publisher","first-page":"156908","DOI":"10.1016\/j.phymed.2025.156908","volume":"143","author":"C Fang","year":"2025","unstructured":"Fang C, Liu S, Zhang S, Zheng H, Fang G, Chen C, Zhang Y, Yao R, Chen X, Luo R, Li J, Zhong C. Jianpi Huayu decoction enhances the antitumor effect of doxorubicin via piezo1-mediated autophagy in hepatocellular carcinoma. Phytomedicine. 2025;143:156908. https:\/\/doi.org\/10.1016\/j.phymed.2025.156908.","journal-title":"Phytomedicine"},{"key":"3398_CR23","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1002\/tox.23824","volume":"39","author":"L Li","year":"2024","unstructured":"Li L, Jin RJ, Ji L. Pachymic acid ameliorates bleomycin-induced pulmonary fibrosis through inhibiting endoplasmic reticulum stress in rats. Environ Toxicol. 2024;39:5382\u201390. https:\/\/doi.org\/10.1002\/tox.23824.","journal-title":"Environ Toxicol"},{"key":"3398_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/cbin.12090","volume":"48","author":"D Liu","year":"2024","unstructured":"Liu D, Ding J, Li Z, Lu Y. Pachymic acid (PA) inhibits ferroptosis of cardiomyocytes via activation of the AMPK in mice with ischemia\/reperfusion-induced myocardial injury. Cell Biol Int. 2024;48:46\u201359. https:\/\/doi.org\/10.1002\/cbin.12090.","journal-title":"Cell Biol Int"},{"key":"3398_CR25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/bbb\/zbac114","volume":"86","author":"F Li","year":"2022","unstructured":"Li F, Chen M, Ji J, Tang R, Huang J, Zhang X, Yu J. Pachymic acid alleviates experimental pancreatic fibrosis through repressing NLRP3 inflammasome activation. Biosci Biotechnol Biochem. 2022;86:1497\u2013505. https:\/\/doi.org\/10.1093\/bbb\/zbac114.","journal-title":"Biosci Biotechnol Biochem"},{"key":"3398_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1248\/bpb.b22-00440","volume":"46","author":"F Jiang","year":"2023","unstructured":"Jiang F, Zhu T, Yang C, Chen Y, Fu Z, Jiang L, Liu Y. Pachymic Acid Inhibits Growth and Metastatic Potential in Liver Cancer HepG2 and Huh7 Cells. Biol Pharm Bull. 2023;46:35\u201341. https:\/\/doi.org\/10.1248\/bpb.b22-00440.","journal-title":"Biol Pharm Bull"},{"key":"3398_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cbin.12123","volume":"48","author":"W Zhao","year":"2024","unstructured":"Zhao W, Ma J, Zhang Q, Zhang H, Ma W, Li S, Piao Y, Zhao S, Dai S, Tang D. Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. Cell Biol Int. 2024;48:496\u2013509. https:\/\/doi.org\/10.1002\/cbin.12123.","journal-title":"Cell Biol Int"},{"key":"3398_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1158\/0008-5472.CAN-23-0744","volume":"84","author":"H Wang","year":"2024","unstructured":"Wang H, Zhang Y, Tian Y, Yang W, Wang Y, Hou H, Pan H, Pei S, Zhu H, Gu Z, Zhang Y, Dai D, Chen W, Zheng M, Luo Q, Xiao Y, Huang J. DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote Lung Squamous Cell Carcinoma Malignancy and Chemoresistance. Cancer Res. 2024;84:688\u2013702. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0744.","journal-title":"Cancer Res"},{"key":"3398_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/biom14020190","volume":"14","author":"J Zhang","year":"2024","unstructured":"Zhang J, Tang M, Shang J. PPARgamma Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges. Biomolecules. 2024;14:190. https:\/\/doi.org\/10.3390\/biom14020190.","journal-title":"Biomolecules"},{"key":"3398_CR30","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1038\/s44318-025-00460-x","volume":"44","author":"L Wang","year":"2025","unstructured":"Wang L, Wang Y, Ding K, Li Z, Zhang Z, Li X, Song Y, Xie L, Chen Z. YTHDC1 promotes postnatal brown adipose tissue development and thermogenesis by stabilizing PPARgamma. EMBO J. 2025;44:3360\u201380. https:\/\/doi.org\/10.1038\/s44318-025-00460-x.","journal-title":"EMBO J"},{"key":"3398_CR31","doi-asserted-by":"publisher","first-page":"115165","DOI":"10.1016\/j.celrep.2024.115165","volume":"44","author":"S Zhao","year":"2025","unstructured":"Zhao S, Zhu Q, Lee WH, Funcke JB, Zhang Z, Wang MY, Lin Q, Field B, Sun XN, Li G, Ekane M, Onodera T, Li N, Zhu Y, Kusminski CM, Hinds TD Jr, Scherer PE. The adiponectin-PPARgamma axis in hepatic stellate cells regulates liver fibrosis. Cell Rep. 2025;44:115165. https:\/\/doi.org\/10.1016\/j.celrep.2024.115165.","journal-title":"Cell Rep"},{"key":"3398_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12944-025-02490-0","volume":"24","author":"L Wang","year":"2025","unstructured":"Wang L, Wei L, Chen X, Xiong J. Arachidonic acid suppresses lung cancer cell growth and modulates lipid metabolism and the ERK\/PPARgamma signaling pathway. Lipids Health Dis. 2025;24:114. https:\/\/doi.org\/10.1186\/s12944-025-02490-0.","journal-title":"Lipids Health Dis"},{"key":"3398_CR33","doi-asserted-by":"publisher","first-page":"116097","DOI":"10.1016\/j.bcp.2024.116097","volume":"222","author":"R Rapuano","year":"2024","unstructured":"Rapuano R, Riccio A, Mercuri A, Madera JR, Dallavalle S, Moricca S, Lupo A. Proliferation and migration of PC-3 prostate cancer cells is counteracted by PPARgamma-cladosporol binding-mediated apoptosis and a decreased lipid biosynthesis and accumulation. Biochem Pharmacol. 2024;222:116097. https:\/\/doi.org\/10.1016\/j.bcp.2024.116097.","journal-title":"Biochem Pharmacol"},{"key":"3398_CR34","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41416-022-02096-8","volume":"128","author":"A Hartley","year":"2023","unstructured":"Hartley A, Ahmad I. The role of PPARgamma in prostate cancer development and progression. Br J Cancer. 2023;128:940\u20135. https:\/\/doi.org\/10.1038\/s41416-022-02096-8.","journal-title":"Br J Cancer"},{"key":"3398_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13046-020-1528-x","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Dai W, Mao Y, Wu L, Li J, Chen K, Yu Q, Kong R, Li S, Zhang J, Ji J, Wu J, Mo W, Xu X, Guo C. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1alpha\/PPAR-gamma\/PKM2-mediated glycolysis. J Exp Clin Cancer Res. 2020;39:24. https:\/\/doi.org\/10.1186\/s13046-020-1528-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"3398_CR36","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1158\/0008-5472.CAN-25-3289","volume":"86","author":"H Tao","year":"2026","unstructured":"Tao H, Gu Y, Wang X, Sun Y, Wang L, Dai Y, Zhu M, Hu Z, Li Y, Kong M, Gao K, Wan X. NSD1-Mediated PPARgamma Methylation Enhances PTEN Activity to Suppress Glycolysis and Tumor Progression in Endometrial Cancer. Cancer Res. 2026;86:2464\u201386. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-3289.","journal-title":"Cancer Res"},{"key":"3398_CR37","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s11010-022-04419-y","volume":"477","author":"J Feng","year":"2022","unstructured":"Feng J, Lu M, Li W, Li J, Meng P, Li Z, Gao X, Zhang Y. PPARgamma alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation. Mol Cell Biochem. 2022;477:1959\u201371. https:\/\/doi.org\/10.1007\/s11010-022-04419-y.","journal-title":"Mol Cell Biochem"},{"key":"3398_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41419-023-05770-8","volume":"14","author":"D Shen","year":"2023","unstructured":"Shen D, Deng Z, Liu W, Zhou F, Fang Y, Shan D, Wang G, Qian K, Yu M, Zhang Y, Ju L, Xiao Y, Wang X. Melatonin inhibits bladder tumorigenesis by suppressing PPARgamma\/ENO1-mediated glycolysis. Cell Death Dis. 2023;14:246. https:\/\/doi.org\/10.1038\/s41419-023-05770-8.","journal-title":"Cell Death Dis"},{"key":"3398_CR39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1186\/s12967-024-05847-8","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Liu L, Li B. Role of ENO1 and its targeted therapy in tumors. J Transl Med. 2024;22:1025. https:\/\/doi.org\/10.1186\/s12967-024-05847-8.","journal-title":"J Transl Med"},{"key":"3398_CR40","doi-asserted-by":"publisher","first-page":"e2403818","DOI":"10.1002\/advs.202403818","volume":"12","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, He X, Yang X, Hong Z, Xu Y, Xu J, Zheng H, Zhang L, Zuo Z, Hu X. CircFndc3b Mediates Exercise-Induced Neuroprotection by Mitigating Microglial\/Macrophage Pyroptosis via the ENO1\/KLF2 Axis in Stroke Mice. Adv Sci. 2025;12:e2403818. https:\/\/doi.org\/10.1002\/advs.202403818.","journal-title":"Adv Sci"},{"key":"3398_CR41","doi-asserted-by":"publisher","first-page":"149735","DOI":"10.1016\/j.bbrc.2024.149735","volume":"706","author":"X Luo","year":"2024","unstructured":"Luo X, Luan C, Zhou J, Ye Y, Zhang W, Jain R, Zhang E, Chen N. Glycolytic enzyme Enolase-1 regulates insulin gene expression in pancreatic beta-cell. Biochem Biophys Res Commun. 2024;706:149735. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149735.","journal-title":"Biochem Biophys Res Commun"},{"key":"3398_CR42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/mc.23719","volume":"63","author":"H Ma","year":"2024","unstructured":"Ma H, Kong L, Liu L, Du Y, Zhu X, Wang J, Zhao W. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway. Mol Carcinog. 2024;63:1221\u201334. https:\/\/doi.org\/10.1002\/mc.23719.","journal-title":"Mol Carcinog"},{"key":"3398_CR43","first-page":"1275","volume":"12","author":"Y Santana-Rivera","year":"2020","unstructured":"Santana-Rivera Y, Rabelo-Fernandez RJ, Quinones-Diaz BI, Grafals-Ruiz N, Santiago-Sanchez G, Lozada-Delgado EL, Echevarria-Vargas IM, Apiz J, Soto D, Rosado A, Melendez L, Valiyeva F, Vivas-Mejia PE. Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells. Am J Transl Res. 2020;12:1275\u201392.","journal-title":"Am J Transl Res"},{"key":"3398_CR44","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/jcmm.14763","volume":"24","author":"R Chen","year":"2020","unstructured":"Chen R, Li D, Zheng M, Chen B, Wei T, Wang Y, Li M, Huang W, Tong Q, Wang Q, Zhu Y, Fang W, Guo L, Fang S. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K\/Akt pathway via ENO1. J Cell Mol Med. 2020;24:2123\u201334. https:\/\/doi.org\/10.1111\/jcmm.14763.","journal-title":"J Cell Mol Med"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03398-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:40Z","timestamp":1792096900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03398-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":44,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3398"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03398-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional animal ethics committee has approved all animal procedures prior to their initiation (No. 2025DW-057-01).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"271"}}